Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KLINIK FOR TANDSUNDHED, HOLISTISKE TANDLÆGER ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   29.8% 6.1% 4.5% 2.3% 1.5% 1.8% 17.3% 17.1%   Credit score (0-100)   1 40 46 63 76 71 9 10   Credit rating   C BBB BBB BBB A A BB BB   Credit limit (kDKK)   -0.0 0.0 0.0 0.0 8.4 1.6 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,522 3,256 2,896 3,461 2,966 2,919 0.0 0.0   EBITDA   -2,093 1,245 1,101 1,408 860 1,000 0.0 0.0   EBIT   -2,146 1,194 1,037 1,347 789 966 0.0 0.0   Pre-tax profit (PTP)   -2,367.0 1,192.9 1,030.5 1,341.6 806.9 1,009.0 0.0 0.0   Net earnings   -1,847.8 996.8 737.2 1,046.4 629.0 787.3 0.0 0.0   Pre-tax profit without non-rec. items   -2,367 1,193 1,031 1,342 807 1,009 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   236 184 120 112 116 81.9 0.0 0.0   Shareholders equity total   -1,293 -297 441 1,387 1,016 1,203 278 278   Interest-bearing liabilities   0.0 753 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,121 838 828 2,093 1,463 1,745 278 278   Net Debt   -577 599 -207 -125 -188 -502 -278 -278     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,522 3,256 2,896 3,461 2,966 2,919 0.0 0.0   Gross profit growth   -38.3% -7.6% -11.0% 19.5% -14.3% -1.6% -100.0% 0.0%   Employees   6 5 0 4 4 4 0 0   Employee growth %   0.0% -16.7% -100.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,121 838 828 2,093 1,463 1,745 278 278   Balance sheet change%   6.1% -60.5% -1.1% 152.7% -30.1% 19.2% -84.0% 0.0%   Added value   -2,093.0 1,245.3 1,101.3 1,408.1 849.8 1,000.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -26 -103 -129 -69 -68 -68 -82 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -60.9% 36.7% 35.8% 38.9% 26.6% 33.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -78.7% 52.5% 105.7% 92.2% 45.8% 63.0% 0.0% 0.0%   ROI %   -341.9% 317.2% 173.8% 147.4% 67.8% 91.1% 0.0% 0.0%   ROE %   -116.4% 67.4% 115.3% 114.5% 52.4% 70.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -37.9% -26.2% 53.2% 66.3% 69.4% 69.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   27.6% 48.1% -18.8% -8.9% -21.8% -50.2% 0.0% 0.0%   Gearing %   0.0% -253.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   245.7% 0.2% 1.7% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.5 0.5 1.6 2.7 2.8 2.9 0.0 0.0   Current Ratio   0.5 0.5 1.6 2.7 2.8 2.9 0.0 0.0   Cash and cash equivalent   577.2 153.9 206.6 125.0 187.9 501.8 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,605.3 -557.8 242.5 1,196.0 811.9 1,033.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -349 249 0 352 212 250 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -349 249 0 352 215 250 0 0   EBIT / employee   -358 239 0 337 197 242 0 0   Net earnings / employee   -308 199 0 262 157 197 0 0